Latest debt-to-equity ratio
Ligand Pharmaceuticals Debt-to-equity ratio
Direct answer
Ligand Pharmaceuticals's debt-to-equity ratio is 116.94%.
The verified market snapshot reports 116.94%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 116.94%
Explore related company data
View Ligand Pharmaceuticals's market capitalizationView Ligand Pharmaceuticals's p/e ratioView Ligand Pharmaceuticals's price-to-book ratioView Ligand Pharmaceuticals's return on equityView Ligand Pharmaceuticals's dividend yieldView Ligand Pharmaceuticals's 52-week price rangeView Ligand Pharmaceuticals's revenue growthView Ligand Pharmaceuticals's profit marginView all Ligand Pharmaceuticals key metricsReturn to Ligand Pharmaceuticals profile